Production (Stage)
Acadia Healthcare Company, Inc.
ACHC
$22.53
-$0.43-1.87%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 3.16B | 3.15B | 3.12B | 3.06B | 2.99B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 3.16B | 3.15B | 3.12B | 3.06B | 2.99B |
Cost of Revenue | 1.83B | 1.80B | 1.78B | 1.74B | 1.71B |
Gross Profit | 1.32B | 1.35B | 1.35B | 1.32B | 1.29B |
SG&A Expenses | 237.38M | 237.57M | 235.59M | 231.98M | 227.57M |
Depreciation & Amortization | 160.28M | 149.60M | 145.43M | 141.18M | 137.13M |
Other Operating Expenses | 453.72M | 440.79M | 421.01M | 412.92M | 399.14M |
Total Operating Expenses | 2.68B | 2.63B | 2.58B | 2.53B | 2.47B |
Operating Income | 471.87M | 522.28M | 543.86M | 530.99M | 523.39M |
Income Before Tax | 256.50M | 341.88M | 383.84M | -2.13M | -12.16M |
Income Tax Expenses | 61.73M | 77.40M | 93.12M | -5.95M | -8.71M |
Earnings from Continuing Operations | 194.78 | 264.48 | 290.71 | 3.82 | -3.45 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -7.18M | -8.87M | -9.99M | -8.94M | -7.85M |
Net Income | 187.60M | 255.61M | 280.73M | -5.12M | -11.30M |
EBIT | 471.87M | 522.28M | 543.86M | 530.99M | 523.39M |
EBITDA | 632.15M | 671.87M | 689.29M | 672.17M | 660.52M |
EPS Basic | 2.05 | 2.79 | 3.07 | -0.06 | -0.13 |
Normalized Basic EPS | 1.87 | 2.42 | 2.72 | 2.71 | 2.73 |
EPS Diluted | 2.04 | 2.78 | 3.04 | -0.09 | -0.15 |
Normalized Diluted EPS | 1.86 | 2.41 | 2.71 | 2.70 | 2.72 |
Average Basic Shares Outstanding | 366.77M | 366.48M | 365.95M | 365.40M | 364.81M |
Average Diluted Shares Outstanding | 368.26M | 368.23M | 368.11M | 367.09M | 366.60M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |